News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nomir Medical Presents Positive Onychomycosis Data for its Noveon® Dual Wavelength Device



9/10/2008 9:15:12 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Nomir Medical Technologies, announced today the presentation of positive in vitro and in vivo human data for its Noveon® direct optical energy device for treating onychomycosis (toe nail fungus). The studies demonstrated that treatment with the Noveon resulted in complete photo-inactivation of the fungi that cause onychomycosis at safe energy densities and temperatures. Nomir will present the data at the New Cardiovascular Horizons “Wound Management of the Diabetic Foot and Wound Healing” conference in New Orleans. The abstract is available online at http://www.newcvhorizons.com/uploads/Abstract_701].pdf. A pivotal product registration trial for Noveon for the onychomycosis indication is currently underway.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES